NEW YORK, July 5 - Genomic Solutions said Thursday it expected its second-quarter revenues to be lower than it had initially forecast, because some customers had postponed their orders and because the economy is beginning to slow.

The company expects revenues for the quarter to total between $4.5 and $4.6 million, largely unchanged from the company's second-quarter 2000 revenues of $4.5 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.